Revance Therapeutics (RVNC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RVNC | AVIR | UPB | ||
| Company | Revance Therapeutics | Atea Pharmaceuticals Inc | Upstream Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.65 | 4.73 | 6.92 | ||
| High | 3.66 | 4.89 | 7.08 | ||
| Low | 3.65 | 4.67 | 6.86 | ||
| Latest | 3.65 | 4.87 | 6.98 | ||
| Change | +0.01 | +0.09 | unch | ||
| % Change | +0.27% | +1.99% | unch | ||
| Volume | 4,123,100 | 159,800 | 340,900 | ||
| 20-Day Average Volume | 2,900,350 | 358,130 | 524,760 | ||
| Previous Close | 3.64 | 4.78 | 6.98 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.53 | 4.74 | 7.14 | ||
| 20-Day Raw Stochastic | 89.36% | 77.55% | 42.05% | ||
| 20-Day Relative Strength | 52.71 | 53.46 | 43.88 | ||
| Weighted Alpha | -53.44 | +30.70 | -2.94 | ||
| Today's Opinion | 24% Sell | 40% Buy | 88% Sell | ||
| Previous Opinion | 24% Sell | 40% Buy | 88% Sell | ||
| Last Month's Opinion | 88% Sell | 24% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.27% since 01/29/25 | +3.62% since 07/14/26 | -2.24% since 07/14/26 | ||
| Low | 3.62 on 01/30/25 | 4.64 on 07/17/26 | 6.80 on 07/20/26 | ||
| High | 3.66 on 02/05/25 | 4.97 on 07/20/26 | 7.34 on 07/16/26 | ||
| 1-Month | |||||
| %Chg | +18.12% since 01/03/25 | +11.70% since 06/18/26 | +11.68% since 06/18/26 | ||
| Low | 3.23 on 01/10/25 | 4.30 on 06/25/26 | 6.24 on 06/23/26 | ||
| High | 3.70 on 01/17/25 | 5.03 on 07/02/26 | 8.00 on 07/09/26 | ||
| 3-Month | |||||
| %Chg | -37.50% since 11/05/24 | -11.78% since 04/21/26 | -24.62% since 04/21/26 | ||
| Low | 3.01 on 12/09/24 | 4.04 on 05/18/26 | 5.85 on 06/12/26 | ||
| High | 5.97 on 11/06/24 | 5.83 on 05/05/26 | 9.72 on 04/23/26 | ||
| 6-Month | |||||
| %Chg | +19.28% since 08/05/24 | +38.35% since 01/21/26 | -77.90% since 01/21/26 | ||
| Low | 2.80 on 08/07/24 | 3.53 on 01/22/26 | 5.85 on 06/12/26 | ||
| High | 6.65 on 08/19/24 | 6.45 on 03/10/26 | 32.83 on 01/27/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 381,023 | 382,129 | 379,852 | ||
| Shares Outstanding, K | 104,390 | 80,027 | 54,420 | ||
| Annual Sales | 234,040,000 | 0 | 2,850,000 | ||
| Annual Net Income | -323,990,000 | -158,350,000 | -143,440,000 | ||
| Last Quarter Sales | 59,880,000 | 0 | 1,030,000 | ||
| Last Quarter Net Income | -38,120,000 | -45,440,000 | -40,590,000 | ||
| 60-Month Beta | 0.90 | 0.31 | 1.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 11/07/24 | -0.57 on 05/12/26 | -0.75 on 05/13/26 | ||
| Earnings Date | 02/26/25 | 08/06/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||